Top

Published in:

01-10-2017 | Editorial

Shining a White Light on Barrett’s Esophagus: What Does the BING Classification Bring?

Author: Shajan Peter

Published in: Digestive Diseases and Sciences | Issue 10/2017

Excerpt

Barrett’s esophagus (BE) refers to the histological transformation of the squamous epithelium of the distal esophagus into specialized intestinal metaplasia. Given its potential to progress from low-grade dysplasia (LGD) to high-grade dysplasia (HGD) to esophageal adenocarcinoma (EAC), it is important to accurately diagnose and survey these patients who have these pathologic findings. Current guidelines recommend detailed visualization by endoscopy and obtain biopsies in a random four-quadrant fashion every 1–2 cm as well as targeted biopsies of any suspicious lesions [1, 2]. In effect, histology remains the hallmark for diagnosis. …

Shaheen NJ, Falk GW, Iyer PG, Gerson LB, American College of G. ACG Clinical Guideline. Diagnosis and management of Barrett’s esophagus. Am J Gastroenterol. 2016;111:30–50; quiz 1.

Wani S, Rubenstein JH, Vieth M, Bergman J. Diagnosis and management of low-grade dysplasia in Barrett’s esophagus: expert review from the clinical practice updates Committee of the American Gastroenterological Association. Gastroenterology. 2016;151:822–835.CrossRefPubMed

Cotton CC, Duits LC, Wolf WA, et al. Spatial predisposition of dysplasia in Barrett’s esophagus segments: a pooled analysis of the SURF and AIM dysplasia trials. Am J Gastroenterol. 2015;110:1412–1419.CrossRefPubMedPubMedCentral

Curvers WL, ten Kate FJ, Krishnadath KK, et al. Low-grade dysplasia in Barrett’s esophagus: overdiagnosed and underestimated. Am J Gastroenterol. 2010;105:1523–1530.CrossRefPubMed

Vennalaganti P, Kanakadandi V, Goldblum JR, et al. Discordance among pathologists in the United States and Europe in diagnosis of low-grade dysplasia for patients with Barrett’s esophagus. Gastroenterology. 2017;152:564–570.CrossRefPubMed

Qumseya BJ, Wang H, Badie N, et al. Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett’s esophagus: a meta-analysis and systematic review. Clin Gastroenterol Hepatol. 2013;11:1562–1570.CrossRefPubMedPubMedCentral

Kara MA, Peters FP, Rosmolen WD, et al. High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett’s esophagus: a prospective randomized crossover study. Endoscopy. 2005;37:929–936.CrossRefPubMed

Sharma P, Hawes RH, Bansal A, et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett’s oesophagus: a prospective, international, randomised controlled trial. Gut. 2013;62:15–21.CrossRefPubMed

Committee AT, Thosani N, Abu Dayyeh BK, et al. ASGE Technology Committee systematic review and meta-analysis assessing the ASGE Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for adopting real-time imaging-assisted endoscopic targeted biopsy during endoscopic surveillance of Barrett’s esophagus. Gastrointest Endosc. 2016;83:684–698 e7.CrossRef

10.

Sharma P, Bergman JJ, Goda K, et al. Development and validation of a classification system to identify high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus using narrow-band imaging. Gastroenterology. 2016;150:591–598.CrossRefPubMed

11.

Nogales O, Caballero-Marcos A, Clemente-Sanchez A, et al. Usefulness of non-magnifying narrow band imaging in EVIS EXERA III video systems and high-definition endoscopes to diagnose dysplasia in Barrett’s esophagus using the Barrett International NBI group (BING) classification. Dig Dis Sci. (Epub ahead of print). doi:10.1007/s10620-017-4581-3.

12.

Singh M, Gupta N, Gaddam S, et al. Practice patterns among U.S. gastroenterologists regarding endoscopic management of Barrett’s esophagus. Gastrointest Endosc. 2013;78:689–695.CrossRefPubMed

13.

Kandel P, Wallace MB. The role of adjunct imaging in endoscopic detection of dysplasia in Barrett’s esophagus. Gastrointest Endosc Clin N Am. 2017;27:423–446.CrossRefPubMed

14.

Sturm MB, Wang TD. Emerging optical methods for surveillance of Barrett’s oesophagus. Gut. 2015;64:1816–1823.CrossRefPubMedPubMedCentral

15.

Gupta N, Brill JV, Canto M, et al. AGA white paper: training and implementation of endoscopic image enhancement technologies. Clin Gastroenterol Hepatol. 2017;15:820–826.CrossRefPubMed

Title: Shining a White Light on Barrett’s Esophagus: What Does the BING Classification Bring?
Author: Shajan Peter
Publication date: 01-10-2017
Publisher: Springer US
Published in: Digestive Diseases and Sciences / Issue 10/2017
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-017-4694-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Shining a White Light on Barrett’s Esophagus: What Does the BING Classification Bring?

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2017

Early Colorectal Cancer Detected by Machine Learning Model Using Gender, Age, and Complete Blood Count Data

MiR-3910 Promotes the Growth and Migration of Cancer Cells in the Progression of Hepatocellular Carcinoma

Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma

Early Abdominal Imaging Remains Over-Utilized in Acute Pancreatitis

Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease

Accurate Identification of Fatty Liver Disease in Data Warehouse Utilizing Natural Language Processing

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page